Sapphiros

Sapphiros

Consumer diagnostics company offering rapid, at-home tests for infectious diseases and personalized wellness insights.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
investor

€0.0

round
*

$30.0m

Series B
Total Funding000k
Notes (0)
More about Sapphiros
Made with AI
Edit

Sapphiros is a global AI Bio computational biology company that provides solutions to help people make informed decisions. They offer real-time, definitive results through their products, ranging from rapid home tests to advanced laboratory testing services. Sapphiros is a leader in genetic and COVID-19 testing, and are also developing a device that will provide the highest performing diagnostics in the palm of your hand. Additionally, they are creating a convenient patch for rapid, point of care diagnosis. They are also working on proprietary molecular detection technologies that will enable near patient and at-home testing for infectious diseases and generic indications. Sapphiros is backed by a team of experienced healthcare executives and a leading global investment firm, KKR. They are committed to investing in growth stage companies that have the vision and passion to bring transformative new diagnostic technologies to the world.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Sapphiros

Edit
Biocrucible
ACQUISITION by Sapphiros Jul 2021